Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by γ-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 6, 1998, Pages 611-619

  Erhardt, Sophie ^a   Andersson, Bengt ^b   Nissbrandt, Hans ^b   Engberg, Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Hydroxybutyrate; Baclofen; Burst firing; Dopamine; GABA(B) receptors; NCS 382; SCH 50911; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 HYDROXYBUTYRIC ACID; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; BACLOFEN; NCS 382; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; ELECTROPHYSIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CONDUCTION; NONHUMAN; RAT; SUBSTANTIA NIGRA;

ANIMALS; BACLOFEN; BENZOCYCLOHEPTENES; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GABA AGONISTS; GABA ANTAGONISTS; IONTOPHORESIS; MALE; MEMBRANE POTENTIALS; MORPHOLINES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, GABA-B; SODIUM OXYBATE; SUBSTANTIA NIGRA;

EID: 0031806937     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005215     Document Type: Article

References (35)

1. Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth C, Mandel P, Vincendon G, Maitre M (1982) High affinity binding sites for γ-hydroxybutyric acid in rat brain. Life Sci 30:953-961
2. B receptors. J Neural Transm Suppl 35:155-177
3. B receptor antagonist. J Pharmacol Exp Ther 274:1393-1398
4. Colombo G, Agabio R, Bourguignon J, Fadda F, Lobina C, Maitre M, Reali R, Schmitt M, Gessa GL (1995) Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382. Physiol Behav 58:587-590
5. De Feudis FV, Collier B (1970) Conversion of γ-hydroxybutyrate to γ-aminobutyrate by mouse brain in vivo. Experientia 26:1072-1073
6. Della Pietra G, Illiano G, Capano V, Rava R (1966) In vivo conversion of γ-hydroxybutyrate into γ-aminobutyrate. Nature 210:733-734
7. Doherty JD, Stout RW, Roth RH (1975) Metabolism of [1-14 C]γ-hydroxybutyric acid by rat brain after intraventricular injection. Biochem Pharmacol 24:469-474
8. Doherty JD, Hattox SE, Snead OC, Roth RH (1978) Identification of endogenous γ-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain. J Pharmacol Exp Ther 207:130-139
9. B-receptors. Naunyn Schmiedebergs Arch Pharmacol 348:491-497
10. B-receptors activation alters the firing pattern of dopamine neurons in the rat substantia nigra. Synapse 15:229-238
11. Engberg G, Elverfors A, Jonason J, Nissbrandt H (1997) Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity. Synapse 25:215-226
12. Gessa GL, Crabai F, Vargiu L, Spano PF (1968) Selective increase of brain dopamine induced by γ-hydroxybutyrate: study of the mechanism of action. J Neurochem 15:377-381
13. Grace AA, Bunney BS (1984) The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890
14. Maitre M (1997) The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol 51:337-361
15. Maitre M, Rumigny JF, Cash CD, Mandel P (1983) Subcellular distribution of γ-hydroxybutyrate binding sites in rat brain. Principal localization in the synaptosomal traction. Biochem Biophys Res Commun 110:262-265
16. Maitre M, Hechler V, Vayer P, Gobaille S, Cash CD, Schmitt M, Bourguignon JJ (1990) A specific γ-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther 255:657-663
17. Margolis RK (1969) The effect of γ-hydroxybutyric acid on amino-acid levels in brain. Biochem Pharmacol 18:1243-1246
18. Mitoma C, Neubauer SE (1968) Gamma-hydroxybutyric acid and sleep. Experientia 24:12-13
19. Möhler H, Patel AJ, Balazs R (1976) Gamma-hydroxybutyrate degradation in the brain in vivo: negligible direct conversion to GABA. J Neurochem 27:253-258
20. B-receptor antagonist CGP 35348 antagonises γ-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J Neural Transm 103:1255-1263
21. Nissbrandt H, Elverfors A, Engberg G (1994) Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux. Synapse 17:217-224
22. Roth RH, Giarman NJ (1970) Natural occurrence of gamma-hydroxybutyric acid in mammalian brain. Biochem Pharmacol 21:2111-2121
23. Roth RH, Walters JR, Aghajanian GK (1973) Effect of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Snyder SH, Usdin E (eds) Frontiers in catecholamine research. Pergamon Press, New York, pp 567-574
24. Snead OC (1977) Minireview: gamma-hydroxybutyrate. Life Sci 20:1935-1943
25. B-binding sites: relation to the development of experimental absence seizures. Brain Res 659:147-156
26. B) receptor in the rat brain. Biochem Pharmacol 52:1235-1243
27. Snead OC, Liu CC (1984) Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochem Pharmacol 33:2587-2590
28. Snead OC III, Furner R, Liu CC (1989) In vivo conversion of γ-aminobutyric acid and 1,4-butanediol to γ-hydroxybutyric acid in rat brain: studies using stable isotopes. Biochem Pharmacol 38:4375-4380
29. Stock G, Magnusson T, Andén N-E (1973) Increase in brain dopamine after axotomy or treatment with γ-hydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn Schmiedebergs Arch Pharmacol 278:347-361
30. Tunnicliff G (1992) Significance of γ-hydroxybutyric acid in the brain. Gen Pharmacol 23:1027-1034
31. Vayer P, Mandel P, Maitre M (1987) Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 41:1547-1557
32. Vayer P, Ehrhardt J-D, Gobaille S, Mandel P, Maitre M (1988) γ-hydroxybutyrate distribution and turnover rates in discrete brain regions of the rat. Neurochem Int 12:53-59
33. B-antagonist, CGP 35348, antagonises the effects of baclofen, γ-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn Schmiedebergs Arch Pharmacol 343:173-178
34. Walters JR, Roth RH (1972) Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochem Pharmacol 21:2111-2121
35. Werner G, Mountcastle VB (1963) The variability of central neural activity in a sensory system and its implication for the central reflection of sensory events. J Neurophysiol 26:958-977